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A significant cost reduction is likely if patients who require coronary artery 
bypass grafting with significant carotid stenosis have simultaneous carotid 
endarterectomy and bypass grafting, provided risk is not increased. To 
investigate this issue, we retrospectively identified cases from February 
1977 to May 1994 with first-time isolated carotid endarterectomy, coronary 
bypass, or combined procedures. In the isolated carotid endarterectomy 
population, median age was 69 years and 58% (85/146) were male, as 
compared with 68 years and 68% (68/100) male in the combined group; 
median age of the coronary bypass cohort was 65 years and 76% (381/500) 
male. A significantly higher percentage of patients in the coronary bypass 
versus combined group were in New York Heart Association functional 
class IV. In the combined group there was a significantly higher incidence 
of older age, diabetes, hypertension, hyperlipidemia, renal failure, and 
congestive heart failure. There was no difference among the three groups 
with respect o hospital mortality (0%, 3.4%, and 4.0%, respectively) and 
permanent stroke (0.7%, 1.2%, and 0%, respectively). Hospital costs were 
$4,896, $10,959 and $11,089, respectively, with a savings of $4,766 (30%), 
and Medicare hospital reimbursement was $8,575, $23,071, and $23,071, 
respectively, with a savings of $10,077 (25.3%). Thus, in appropriate 
patients, a combined procedure is cost effective, eliminating a second 
surgical procedure and the cost of the postoperative stay (3.7 - 2.4 days) 
associated with isolated carotid endarterectomy. Riskof permanent stroke 
or death is not increased. (J Thorac Cardiovasc Surg 1996;111:1185-93) 
N umerous previous reports have been directed at resolving the issue of whether patients undergo- 
ing coronary artery bypass grafting (CABG) with 
significant carotid disease (->60% stenosis) should 
have simultaneous or staged procedures or no ca- 
rotid endarterectomy (CEA) at all. This question is 
additionally complicated by the presence or absence 
of cerebral symptoms. In some of these reports the 
risk of combined procedures is significantly higher 
than the additive risk of staged procedures, whereas 
in other reports there is no increased risk. No 
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unequivocal evidence has surfaced to suggest hat 
patients undergoing CABG with significant carotid 
disease are exposed to increased risk of stroke or 
death (or both) in the perioperative phase. How- 
ever, many authors have indicated that CEA re- 
duces the incidence of late stroke in patients with 
60% stenosis or more who have symptoms and, 
recently, in patients who are symptom-free. This 
latter group has substantially increased the number 
of patients who are potential candidates for com- 
bined procedures. 
Actual cost savings, if the risks of permanent 
stroke and eath are not increased, have not been 
previously reported for combining CEA and CABG. 
Therefore, we evaluated consecutive series of pa- 
tients having isolated single CEA, isolated CABG, 
and combined procedures with respect o risk and 
cost savings. 
Patients and methods 
Selection criteria. From February 1977 to May 1994, all 
consecutive patients undergoing isolated CEA were se- 
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Table  I. Patient descriptors--history and physical characteristics 
Combined p Value* 
Variable Isolated CABG Isolated CEA CABG + CEA (overall) 
No. 503 146 100 
Age (yr) 63.6 _+ 10.3 (<0.001) 69.4 _+ 8.9 (0.220) 68.1 _+ 7.5 <0.001 
Male 75.8 (0.134) 58.2 (0.156) 68.0 <0.001 
Previous myocardial infarction 
<6 m0 30.6 (0.043) 4.1 (<0.001) 20.0 <0.001 
>6 mo 22.9 24.7 22.0 0.868 
Unstable angina 75.0 (0.777) 3.4 (<0.001) 73.0 <0.001 
NYHA class IV 51.1 (0.236) 2.1 (<0.001) 44.0 <0.001 
Diabetes 17,1 (0.026) 16.4 (0.059) 27.3 0.046 
Hypertension 45.1 (<0.001) 71.9 (0.603) 76.8 <0.001 
Hyperlipidemia 16.5 (0.017) 25.3 (0.850) 27.3 0.007 
Congestive heart failure 9.2 11.0 16.0 0.119 
Renal failure 4.8 (<0.001) 6.9 (0.035) 16.2 <0.001 
Pulmonary disease 14.1 15A 23.5 0.064 
Current smoking 18.3 26.7 21.0 0.082 
Peripheral vascular disease¢ 9.2 (<0.001) 21.9 (0.015) 37.0 <0.001 
Previous vascular su gery$ 4.0 (0,137) 17:1 (0.061) 8.0 <0.001 
Central nervous ystem symptoms NA 76.7 21.4 <0.001 
Bruit 4.4 (<0.001) 58.9 (0.633) 55.0 <0.001 
Blood pressure (mm Hg) 
Systolic 141 _+ 18 (<0.001) 144 _+ 22 (0.072) 139 _+ 20 <0.001 
Diastolic 77 -+ 13 (0.072) 79 _+ 13 (0.133) 77 _+ 13 <0.001 
Entries are mean -+ standard deviation for continuous variables and percentages for categoric data. Values in parentheses arep values for comparison with 
combined CABG + CEA group by t tests or continuity-corrected X ~ analysis. 
*From analysis of variance or X 2. 
"~Abdominal aorta, thoracic aorta, iliac, femoral, popliteal, subclavian, or vertebral artery. 
SAbdominaI ortic aneurysm, aortoiliac, aortofemoral, or femoral-distal. 
lected for comparison. The patients in this cohort had 
unilateral carotid disease that was hemodynamically sig- 
nificant, defined as 60% stenosis or more, and demon- 
strated by carotid arteriography. Exclusion criteria were 
previous stroke, CEA, CABG, or multiple peripheral 
vascular procedures. Throughout he same period 503 
patients undergoing isolated CABG With no significant 
carotid stenoses, no other cardiac disease, and no prior 
stetnotomy were randomly selected from a group of more 
than 3000 patients. From a statistical standpoint this was 
an adequate number of patients for comparison purposes. 
Exclusion criteria were previous peripheral vascular and 
cardiac procedures, as well as other cardiac disease. Our 
standard policy, except in emergencies, is to perform 
carotid duplex scanning in all patients having procedures 
that involve cardiopulmonary bypass (CPB). The same 
selection and exclusion criteria were applied to patients 
having combined CEA and CABG. 
Patients in all three groups were valuated for certain 
historical aspects, selected physical findings, coronary and 
carotid arteriographic findings, as well as selected intra- 
operative considerations such as the procedures per- 
formed and intraoperative findings. Outcomes such as 
selected complications including permanent neurologic 
deficit and hospital mortality were evaluated. These char- 
acteristics are defined in Tables I through IV. 
Cost evaluation. Hospital costs were derived from a 
computer database comprised of cost related to the 
Operating room personnel and equipment, intensive care 
unit, pharmacy, laboratory services, respiratory therapy, 
central services, radiology, cardiac rehabilitation, vascular 
laboratory, cardiology/EKG, and nutritional supplements. 
The costs for five patients from each group (CEA, CABG, 
and combined) with average hospital stays were selected 
at random and averaged. Exclusion criteria were previous 
cardiac operations or stroke and any cardiac operation in 
addition to CABG for the study group. 
Current cost data regarding hospital costs and Medi- 
care DRG 107 (without cardiac catheterization) reim- 
bursement are presented in Table V. 
Surgical methods. ~adl patients undergoing CEA were 
intraoperatively monitored with eleCtroencephalography. 
A shunt was not used unless electroencephalographic 
changes indicated cerebral ischemia of theoperative side. 
In these instances a shunt was used for the performance of
endarterectomy and partial closure of the arteriotomy. In 
the majority of cases, primary closure of the carotid 
arteriotomy was performed. However, a patch graft of 
autogenous aphenous vein or polytetrafluoroethylene* 
was used when deemed necessary because of the relatively 
small size of the artery: 
Standard CPB with cannuiation of the ascending aorta 
and bicaval cannulation via the right atrium was used for 
patients undergoing CABG. In virtually all of the patients, 
*Polytetrafluoroethylene manufactured byW. L. Gore & Asso- 
ciates, Inc., Elkton, Md., and Impra, Inc., Flagstaff, Ariz. 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 111, Number 6 
Daily et aL 1187 
Table II, Patient descriptors--angiographic and 
surgical data 
Isolated Combined p 
Variable CABG CABG + CEA Value 
No. 503 100 
Extent of disease 
Single 4.6 1.0 
Double 23.3 23.2 0.249 
Triple 72.2 75.8 
Left main 11.7 20.0 0.038 
Scheduling 
Elective 80.5 93.0 
Urgent 7.4 5.0 0.005 
Emergency 12.1 2.0 
Time (min) 
CPB 77 ± 29 73 ± 24 0.136 
Aortic crossclamp 35 ± 15 34 ± 14 0.639 
No. of times aorta cross- 
clamped 
0-2 10.1 5.6 
3-4 61.1 73.0 0.092 
5+ 28.9 21.4 
No. of grafts 
1-2 11.1 6.0 
3 20.5 27.0 
4 26.6 38.0 0.020 
5 20.5 17.0 
6+ 21.3 i2.0 
Average no. of grafts 4.2 ± 1.3 4.0 ± 1.0 NS 
Myocardial protection 
Cardioplegia 5.6 8.0 
Intermittent crossclamping 94.4 92.0 0.480 
Lowest perfusion tempera- 30.2 _+ 1.3 30.1 ± 1.5 NS 
ture (° C) 
Normal aorta 96.6 92.9 0.151 
Entries are mean -+ standard deviation for continuous 
percentages for categoric data. p Value is from t test 
corrected X a test. NS, Not significant. 
variables and 
or continuity- 
body temperature was maintained at 30 ° C. Intermittent 
aortic crossclamping was used for performance of the 
distal grafts in more than 90% of patients with isolated 
CABG or combined procedures, as previously described. 1 
In the remaining patients multiple-dose cardioplegia with 
single aortic crossclamping was used at the discretion of 
the primary surgeon to reduce the risk of atheroemboli- 
zation or if the ascending aorta was arteriosclerotic as
assessed by palpation. Since July 1992, all patients to 
undergo CPB procedures have been given vitamin E, 
vitamin C, and allopurinol by the following dose schedule: 
600 mg of allopurinol, 400 units of vitamin E, and 500 mg 
of vitamin C 8 hours and 4 hours before the operation. In 
all patients having both procedures, median sternotomy 
was first performed along with harvesting of the required 
saphenous veins or internal thoracic arteries. CEA was 
performed as described earlier. After completion f CEA, 
the incision in the neck was left open and a sump tube was 
placed in the incision for continued rainage during the 
performance of CABG. 
Table III. Patient descriptors--angiographic and 
surgical data 
Isolated Combined 
Variable CEA CABG + CEA p Value 
No. 146 100 
Left CEA 52.0 51.0 0.978 
Right CEA 48.0 49.0 
Stenosis* 
<25% 2.1 4.1 
25%-50% 7.5 4.1 
51%-75% 14.4 10.3 0.358 
76%-99% 76.0 80.4 
100% 0.0 1.0 
Ulceration* 
->2 mm 30.8 18.0 0.034 
Scheduling 
Elective 84.3 93.0 
Urgent 11.6 5.0 0.119 
Emergency 4.1 2.0 
Shunt used 27.4 23:0 0.530 
Patch used 14.4 10.0 0.411 
Entries are percentages. 
p Value is from continuity-corrected ~ tesic. 
*Ulceration i artery undergoing endarterectomy. 
Statistical methods. To compare demographic, histori- 
cal, and physical examination findings among the three 
groups of patients, we used an analysis of variance or )(2 test. 
When the overallp value was significant, pair-wise tests were 
performed to compare ach isolated group with the com- 
bined group (t tests and continuity-adjusted X z with the 
Bonferroni correction for two tests). Variables relevant to 
one isolated group were compared with those for the com- 
bined group by means of t tests and continuity-adjusted X z 
tests. In instances inwhich all cell sizes were too small for a 
valid X a analysis, Fisher's exact est was used. 
Results 
The isolated and combined groups differed with 
respect o a number  of demographic, historical, and 
physical examination findings (see Table I). The 
combined group was Significantly older and more 
likely to be male than the isolated CABG group but 
was not significantly different from the isolated CEA 
group. The prevalence of recent myocardial infarc- 
tion, history of unstable angina, and New York 
Heart  Association anginal class IV was about the 
same for the combined and isolated CABG groups, 
but much lower for the isolated CEA group. The 
combined group did not differ from the isolated 
CEA group in history of diabetes, hypertension, 
hyperlipidemia, nd renal failure but showed higher 
rates of these problems than seen in the isolated 
CABG group. The combined group had a higher 
rate of peripheral vascular disease than both groups 
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Table IV. Results 
Variable Isolated CABG Isolated CEA Combined CABG + CEA 
503 146 100 No. 
Complications 
Perioperative myocardial infarction 
Bleeding necessitating reoperation 
Leg wound infection 
Respiratory insufficiency 
Renal failure 
Low cardiac output syndrome* 
Neck hematoma 
Neck infection 
Morbidity and mortality 
Permanent neurologic deficit 
Hospital mortality 
Total permanent neurologic deficit and hospital mortality 
Length of hospital stay (postoperative days) 
1.6 (1.000) 1.0 
5:8 (1.000) 5.0 
4.4 (1.000) 4.0 
6.2 (0.278) 9.0 
2.2 (0.047) 6.0 
6.4 (0.490) 4.0 
3.4 (0.406) 1.0 
1.4 (0.516) 0 
1.2 0.7 0 
3.4 0 4.0 
4.6 0.7 4.0 
9.0 -+ 6.8 3.7 -+ 2.4 10.3 _+ 5.1 
Entries are percentages or mean _+ standard eviation, p Values (in parentheses) are from t tests or Fisher's exact test comparing isolated and combined 
groups. 
*Intraaortic balloon pump or inotropic support. 
with isolated procedures. Despite an overall group 
difference for previous vascular operations, how- 
ever, the rates seen in the isolated groups were not 
different from those for the combined groups after 
the Bonferroni correction to the significance level. 
The prevalence of carotid bruit in the combined 
group was similar to that observed for the isolated 
CEA group and much higher than that in the 
isolated CABG group. Neurologic symptoms were 
more common in the CEA group. Because of the 
large sample size for isolated CABG, the slightly 
elevated systolic blood pressure in the isolated 
CABG group was significantly higher than that in 
the combined group, whereas the even higher mean 
pressure in patients having isolated CEA was not 
different from that for the patients having combined 
procedures. 
The extent of coronary artery disease and surgical 
data for the combined group and the isolated 
CABG group was fairly similar (see Table II). The 
combined group had a few more patients with triple 
vessel disease, but the overall distribution was not 
statistically different from that in the isolated group. 
However, left main disease was more prevalent in 
the combined group. The reason for the statistical 
difference between the groups with respect o the 
number of grafts implanted was that the combined 
group had a higher proportion of patients receiving 
four grafts, and the distribution was more even in 
the isolated group. However, the average number of 
grafts per patient was not significantly different. A 
higher percentage of patients with Combined proce- 
dures had elective operations rather than urgent or 
emergency operations. 
Patients in the combined group were also similar 
to those in the isolated CEA group with respect o 
carotid stenosis in the artery receiving the endarter- 
ectomy (see Table III). However, the isolated group 
contained a greater percentage of patients having 
ulceration of 2 mm or more. The smaller sample size 
for the isolated group resulted in a nonsignificant 
difference in the rates of elective, urgent, or emer- 
gency operations. 
The rates of complications were low in all groups 
(see Table IV). The combined group did have a 
higher rate of renal failure than the isolated CABG 
group, but the rates of most other complications 
were lower than for the isolated groups although not 
significantly lower. Hospital mortality in patients 
with a combined procedure did not appear to be 
higher than those of the group with isolated CABG, 
and the length of stay in the hospital was not 
significantly increased. Hospital costs and Medicare 
reimbursement for DRG 107 (without cardiac ath- 
eterization) are listed in Table V. 
Discussion 
Outcomes as compared with the literature. Since 
Bernhard, Johnson, and Peterson 2 first reported 
combining CEA with CABG, more than 40 publica- 
tions 3 have presented results and recommendations 
regarding the feasibility or the inappropriateness of 
performing the combined procedures. In 1991, 
Gugulakis, Kalodiki, and Nicolaides 4 summarized 
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Table ¥. Financial data--DRG 107 (without cardiac catheterization) 
Procedure 
CEA CABG Combined Savings 
Hospital cost $4,896 $10,959 
Medicare DRG 107 hospital reimbursement $8,575 $23,071 
Professional fee reimbursement--DRG 107 
Surgical $2,681 $4,709 
Anesthesia $324 $601 
Total Medicare savings--DRG 107 
Total $11,580 $28,381 
$11,089 $4,766 (30%) 
$23,071. $8,575 (27.1%) 
$6,050 $1,340 (18.2%) 
$763 $162 (17.6%) 
$29,884 $10,077 (25.3%) 
the majority of these studies 2'5-24. The studies in- 
cluded 1444 patients with a combined permanent 
neurologic deficit rate of 2.4% and a hospital mortality 
rate of 4.2% for a combined morbidity and mortality 
rate of 6.6%. 2, 5-24 There is approximately an equal 
division between those recommending the combined 
procedure and those suggesting that CEA should not 
be performed simultaneously with CABG. 4 In reports 
published since the 1991 paper of Gugulakis, Kalodiki, 
and Nicolaides, 4 and earlier results not described by 
them, an additional 691 patients have undergone 
combined procedures with a permanent neurologic 
deficit rate of 4.5% and a mortality rate of 4.9%, 
resulting in an overall total morbidity and mortality of 
9.4% 25-3° (Table VI). Clearly, the overall results of 
combined CEA and CABG have not improved with 
time. In 1992 Bass and associates 26reported aperma- 
nent neurologic deficit rate of 12% and a hospital 
mortality rate of 12% in a series of 99 patients from 
three centers. Not surprisingly, they suggested staged 
rather than combined procedures. 
The reported incidence of permanent eurologic 
deficit related to CPB without CEA ranges from 
0.8% 1 to 6.0%, 7 with an average of approximately 
2.0%. 4 Mortality associated with isolated CABG 
currently averages 3.3%. 31 Consequently, the aver- 
age permanent eurologic deficit and mortality rate 
for CABG is 5.3%. Added to the average 2% 
morbidity and mortality rate for CEA, 4 there is a 
7.3% average permanent eurologic deficit and hos- 
pital mortality rate for CEA and CABG performed 
separately. This is higher than in the report of 
Gugulakis, Kalodiki, and Nicolaides, 4 with a total 
permanent eurologic deficit and hospital mortality 
rate of 6.6%. However, some authors 17' 32-34 have 
suggested that combined procedures should be per- 
formed only for neurologic symptoms, whereas oth- 
ers,13, 18, 19, 30,35-37 with results equal to or better 
than combined permanent neurologic deficit and 
Table VI. Results in combined CEA and CABG 
group since 1991 report of Gugulakis, Kalodiki, and 
Nicolaides 4 
No. PND HM Total 
Akins et al. 2s 200 2.5% (5) 3.5% (7) 6.0% 
Bass et al. 26 99 12.0% (12) 12.0% (12) 24.0% 
Halpin et al. 27 133 2.3% (3) 1.5% (2) 3.8% 
Vassilidze t al. 28 33 6.0% (2) 6.0% (2) 12.0% 
Rizzo et al. z9 127 5.5% (7) 5.5% (7) 11.0% 
Maki et al. 3° 99 Z0% (2) 4.0% (4) 6.0% 
691 4.5% (31) 4.9% (34) 9.4% 
PND, Permanent eurologic deficit; HM, hospital mortality; Total, opera- 
tive mortality and permanent eurologic deficit. 
hospital mortality rates of 7.0%, have included neuro- 
logically asymptomatic patients. One reason for per- 
forming combined CEA and CABG was increased risk 
of cerebral vascular accident for patients undergoing 
CABG with significant carotid disease, as suggested 
initially by Fields 3s and later by Faggioli, Curl, and 
Ricotta. 39 However, other authors have not identi- 
fied an increased risk of stroke in patients with 
significant carotid stenosis having isolated 
CABG.40, 41 Barnes and coworkers 42' 43 concluded 
that although asymptomatic carotid disease corre- 
lates poorly with perioperative stroke, the risk of 
late stroke and cardiac death is high. 
Despite the fact that patients undergoing a com- 
bined procedure had more widespread arterioscle- 
rosis and a greater incidence of diabetes, renal 
failure, and left main coronary disease than those 
receiving only CABG, the results of this study do not 
provide any evidence of a consistent trend for higher 
complication or mortality rates than for those un- 
dergoing isolated procedures. The efficacy of CEA 
for symptomatic carotid disease was substantiated 
by the North American Symptomatic Carotid End- 
arterectomy Trial. 44 Earlier reports 45-5° suggested, 
1 1 9 0 Daily et al. 
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but did not prove, that CEA for asymptomatic 
stenosis in the range of 70% to 80% resulted in 
improved long-term results. However, these data 
continued to be debated until the recent publication 
of the Executive Committee for the Asymptomatic 
Carotid Artery Study, 51 proving unequivocally that 
patients with asymptomatic 60% stenosis or more of 
the carotid artery had a 53% reduction in ipsilateral 
stroke over 5 years provided that CEA could be 
performed with a combined permanent neurologic 
deficit and hospital mortality rate of 3% or less. 
Consequently, this study regarding patients who are 
free of symptoms has significantly increased the 
potential number of patients who could benefit from 
combined CEA. 
Selection of patients. Some patients undergoing 
combined CEA and CABG have had a variety of 
carotid lesions. These include both symptomatic and 
asymptomatic lesions 52' 53 and, in one study, bilat- 
eral carotid occlusion. 54 These lesions may result in 
a higher incidence of both permanent neurologic 
deficit and mortality. Similarly, in other studies 
patients undergoing CABG have had cardiac proce- 
dures such as valve replacement. 5~ Furthermore, 
patients with CABG reoperations orvalve replace- 
ment (or both) are at increased risk and have been 
included.31, 56The net effect of these variables is to 
confound interpretation f the results. Therefore, to 
simplify comparison of groups, we randomly se- 
lected 503 patients between February 1977 and May 
1994 undergoing first-time sternotomy with isolated 
CABG. Similarly, patients undergoing isolated CEA 
had only single carotid disease. Patients elected for 
the combined group underwent CABG with no 
additional cardiac procedures and stenosis of only 
one carotid artery without stenosis or occlusion of 
the other carotid artery. Therefore, it was thought 
that comparison of these groups would result in 
more accurate prediction of outcomes for combined 
CABG and CEA. 
Cost evaluation. Hospital costs were determined 
from a computer database described in the Patients 
and methods ection. Combining CEA and CABG 
resulted in a savings to the hospital of $4766 or 30% 
(see Table V). However, determination f the reim- 
bursement of hospital and professional fee compo- 
nents was complicated by numerous health insur- 
ance plans associated with frequent changes in 
reimbursement schedules. These changes were so 
frequent and of such magnitude that comparison 
was, essentially, impossible. Therefore, we selected 
recent patients undergoing the combined proce- 
dure, isolated CEA, and isolated CABG for com- 
parison who primarily had Medicare reimburse- 
ment. These comparisons, as seen in Table V, 
indicate that the reduction in reimbursement is 
$8575 (27.1%) for the hospital component, $1,340 
(18.21%) for the surgical fee, and $162 (17.6%) for 
the anesthetic fee for a total savings of $10,077 
(25.3%) for DRG 107. 
Inferences. Our data indicate that combined 
CEA and CABG can be performed in this group of 
selected patients with an incidence of permanent 
neurologic deficit and hospital mortality no greater 
than for isolated CABG alone. However, much 
larger sample sizes would be required to conclu- 
sively rule out this possibility. The incidence of 
permanent eurologic deficit and hospital mortality 
may be higher in patients with other isk factors uch 
as reoperation, additional procedures, and con- 
tralateral carotid disease. Because it has recently 
been demonstrated that patients with asymptomatic 
carotid disease with 60% stenosis or more are 
conferred significant long-term reduction of risk of 
stroke and death, it is rational to perform CEA with 
CABG from the standpoint of both convenience to
the patient and cost savings to the hospital and 
reimbursing agency. The magnitude of these savings 
is $4766 (30%) for hospital costs and $8575 (27.1%) 
for Medicare reimbursement of hospital costs. 
There is an additional savings to Medicare of $1340 
(18.2%) for the surgical fee component and $162 
(17.6%) for the anesthetic fee component. 
We thank Elizabeth A. Gilpin, MS, for her assistance 
with the statistical data for this manuscript. 
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Discussion 
Dr. David A. Fullerton (Denver, Colo.). All of us are in 
the process of carefully scrutinizing the financial aspects 
of our surgical practices. I believe one of the most 
effective ways to control costs is to control complications. 
Stroke is both an expensive and a devastating complica- 
tion after CABG, and the leading cause of death after 
CEA is myocardial infarction, so you tackled an extremely 
difficult and important problem. 
Your study is outstanding for a couple of reasons. First, 
your surgical results are excellent, clearly among the best 
that have been published. Furthermore, your stroke rate 
was extremely low despite the fact that you stacked the 
odds against yourself by using intermittent aortic occlu- 
sion, which some suggest increases the risk of stroke 
during cardiac operations. 
Another reason your study is important is that it is 
extremely difficult to obtain accurate financial data. Your 
study stands alone in that regard. 
Before reading your manuscript I favored a staged 
proc dure, but I think you have argued persuasively that it 
is safe to do a combined procedure and financially advis- 
able to do so. 
I wonder if you might outline a couple of things? Would 
you now advocate doing a combined procedure on all 
patients who have both carotid and coronary disease? If 
not, how do you stratify the surgical strategy? Who should 
h ve CEA first and conversely who should have CABG 
first? 
Dr. Daily. I will take the carotid issue separately. The 
recent study that I just alluded to used the angiographic 
stenosis figure of 60% or greater with asymptomatic 
carotid disease. In that particular study they found a 53% 
reduction in ipsilateral stroke over 5 years. I don't think 
there is much dispute about symptomatic carotid arteries. 
It has been clear for a long time that hese patients 
significantly benefit by CEA. 
I think a patient with significant carotid disease and 
cor nary disease becomes a candidate for a combined 
procedure provided there are no other surgical consider- 
ations, such as mitral valve replacement or contralateral 
or bilateral occlusion of the carotid arteries. In those cases 
we do not have survival data or operative data. I think 
conclusions have to be limited to the same subset that we 
have reported for the same conclusions to be drawn 
regarding the safety of the procedure. 
Dr. Harold Urschel, Jr. (Dallas, Tex.). In most people's 
hands combined CEA and CABG has a higher morbidity 
rate than either alone. Each one of us has to assess 
whether we can perform with the same proficiency as Dr. 
Daily and save money. In 1975 at the meeting of The 
American Association for Thoracic Surgery we presented 
a group of patients who underwent combined CABG and 
CEA operations. Indications were based on the anatomy 
(had to have greater than 60% diameter estrictions in 
two dimensions) plus symptoms. It was a clinical decision 
whether they were had staged or concomitant operations. 
The same is true today. Since that time we have operated 
on more than 500 patients with both coronary artery and 
carotid artery disease. It wasn't until 1986 that we could 
say that the mortality and morbidity warranted combined, 
simultaneous procedures. Some patients have bilateral 
carotid artery disease as well as coronary artery obstruc- 
tion. In Holland more than 1100 bilateral CEAs were 
performed simultaneously without higher risk. In our 
country we do not perform bilateral simultaneous carotid 
procedures because of the possible injury to the recurrent 
laryngeal nerve and the malpractice environment. How- 
ever, on the basis of cost, I'm sure the health maintenance 
organizations would favor performing simultaneous bilat- 
eral CEAs to save the 23% requiring a second operation. 
This might also be indicated in the patient with coronary 
artery disease. It is important that the same surgical team 
perform both operations. If you bring in a separate carotid 
vascular team, you cannot stay under 30 minutes for each 
carotid procedure. Each of us should look carefully at our 
own results in evaluating Dr. Daily's data before we try to 
emulate it. 
Dr. D. Craig Miller (Stanford, Calif). What was the 
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difference in operative time for the combined versus the 
single operations? 
Dr. Daily. The additional time for the CEA really was 
just for the performance of the incision to expose the 
artery and for the CEA itself, because the incision for the 
carotid artery was closed simultaneously with the sternot- 
omy incision. I would say the additional time was 30 
minutes or less. 
Dr. Steven Guyton (Seattle, Wash.). One of the impor- 
tant concerns here is who is saving money. In this situation 
Medicare certainly saves money because they do not have 
to pay out more for the CABG. However, one of the 
concerns that will come up I'm sure is that for your 
hospital there is a certain margin when you perform 
CABG. By increasing the costs of the operation because 
of the additional time in the operating room or additional 
potential complications, which you did not have but many 
people do, you may wipe out that margin. You may find 
that as you combine procedures like this you increase the 
volume of cases, but by doing more cases and having no 
margin you may wipe out the economic viability of surgical 
practices or hospitals. It is very important to understand 
that the costs associated with surgery are the costs that are 
incurred by the institutions that are performing them, not 
the institutions that are paying for them. 
Dr. Daily. I believe that the institution in which the 
procedure isperformed would have to separately consider 
the financial consideration. 
Bound vo lumes  ava i lab le  to subscr ibers  
Bound volumes of The Journal of Thoracic and Cardiovascular Surgery are available to subscribers (only) for the 1996 issues 
from the Publisher, at a cost of $100.50 for domestic, $128.94 for Canadian, and $120.50 for international subscribers for Vol. 111 
(January-June) and Vot. 112 (July-December). Shipping charges are included. Each bound volume contains asubject and author 
index and all advertising is removed. Copies are shipped within 60 days after publication ofthe last issue of the volume. The binding 
is durable buckram with the Journal name, volume number, and year stamped in gold on the spine. Payment must accompany all
orders. Contact Mosby-Year Book, Inc., Subscription Services, 11830 Westline Industrial Drive, St. Louis, Missouri 63146-3318, 
USA; phone 800-453-4351 or 314-453-4351. 
Subscriptions must be in force to qualify. Bound volumes are not available in place of a regular Journal subscription. 
